5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

IOL Chemicals And Pharmaceuticals Ltd.

•
iolcp.comBSE: 524164NSE: IOLCP
Market Cap₹ 5,680 Cr.
Current Price
High / Low₹ 219 / 67
Stock P/E33.8
Book Value₹ 63
Price to Book1.19
Dividend Yield0.10 %
ROCE10.7 %
ROE7.9 %
Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Drugs: 60.2% • Chemicals: 39.8%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Latest quarter profit grew 89.9% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.83x)
  • Company comfortably covers its interest (13.7x coverage)
  • Company generates healthy free cash flow
  • Institutional investors have been accumulating - FII+DII up 2.7pp

CONS

  • Company has a low return on equity of 7.6% over last 3 years
  • Company has a low return on capital employed of 10.6%
  • Company has delivered a poor profit growth of -20.9% over past five years
  • Valuation is stretched - P/E of 33.8 is well above its own 5-year median (15.5)
  • Company has delivered a poor sales growth of 3.3% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.IOLCP193.5033.795679.760.1064.4089.80756.2637.0810.6513.68
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
563545520504502526523528552568580619756
490481476454452484476465490510523527678
Operating Profit73644450514247636257579379
OPM %12.94%11.75%8.55%9.94%10.11%7.90%8.96%11.93%11.27%10.06%9.87%14.94%10.39%
7788764577-628
Interest4443244443434
Depreciation14161616171819192020202021
Profit before Tax62513238392628454641287187
Tax %24.90%26.05%27.95%25.36%24.34%26.18%26.13%29.58%25.43%25.96%25.30%24.92%25.69%
Net Profit46382328301921323430215364
7.876.443.960.961.010.650.701.081.161.020.701.812.20

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
7119831,6851,8941,9672,1842,2172,1332,0792,3192,524
6088641,2761,3211,3751,9281,9911,9011,8772,0502,238
Operating Profit102120410574592256227232202269286
OPM %14.38%12.16%24.31%30.29%30.09%11.73%10.22%10.86%9.72%11.60%11.31%
16101624182630221011
Interest68645121681616151514
Depreciation3030323639434663728082
Profit before Tax631336533571223189183138184226
Tax %21.25%11.50%29.59%32.25%22.20%25.66%26.13%25.85%26.75%25.33%25.45%
Net Profit528237361445166140135101138168
EPS0.834.9342.1163.3876.2128.2223.8423.073.444.69—
Dividend Payout %0.00%0.00%0.00%4.72%7.92%14.18%16.78%21.68%23.25%4.26%—

COMPOUNDED SALES GROWTH

10 Years:
15%
5 Years:
3%
3 Years:
2%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
-21%
3 Years:
-1%

STOCK PRICE CAGR

10 Years:
21%
5 Years:
12%
3 Years:
30%
1 Year:
75%

RETURN ON EQUITY

10 Years:
23%
5 Years:
9%
3 Years:
8%
Last Year:
8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Feb 17

₹ 0.50

Rs.1.0000 per share(50%)Interim Dividend

2025

Feb 18

₹ 0.40

Rs.4.0000 per share(40%)Interim Dividend

2024

Feb 16

₹ 0.50

Rs.5.0000 per share(50%)Interim Dividend

2023

Feb 17

₹ 0.40

Rs.4.0000 per share(40%)Interim Dividend

2022

Feb 15

₹ 0.40

Rs.4.0000 per share(40%)Interim Dividend

2021

Sep 8

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2020

Nov 17

₹ 0.40

Rs.4.0000 per share(40%)Interim Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital56565757595959595959
1321604087471,2021,3321,4481,5531,6291,740
462452285592438033117134
Trade Payables150158120180239409314469428483
1022140303251179166168178215
Total Liabilities8118471,0101,3471,7522,0222,0672,2812,4102,630
3744064124695125617519331,1701,181
Capital Work in Progress217271948102811002194
00001220212121
263207189188295410326425361371
0000000471514603
Cash & Bank17173015536513821143208198
136210353516531809867189116162
Total Assets8118471,0101,3471,7522,0222,0672,2812,4102,630

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
84126341588522154170290179214
Cash from Investing-23-50-63-184-317-121-119-191-154-198
Cash from Financing-60-70-197-272-58-2-4-9246-29
1-113154-31-0770-13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
48.1952.6252.6252.6252.6252.6257.4862.28
1.631.491.472.592.252.081.724.87
0.070.070.070.020.040.020.020.43
Government0.000.000.000.000.000.000.000.00
50.1145.8245.8444.7745.0945.2840.7832.42

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-11 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Link of Recording

2026-09-10
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-10 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

2026-09-09
General Updates

2026-09-09 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about General Updates

2026-09-02
Shareholders meeting

2026-09-02 - Submission of Voting Results along with Scrutinizer s Report with regard to the 39th Annual General Meeting of the Company

2026-09-02
Shareholders meeting

2026-09-02 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 02, 2026

2026-08-26
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-26 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

2026-08-20
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-20 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Transcript

2026-08-18
Copy of Newspaper Publication

2026-08-18 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Link of Recording

News

Recent coverage and analyst commentary for IOLCP

Loading news…

🤖

AI Stock Analyst

IOL Chemicals And Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login